RecruitingNCT03831126

Stress and Fetal Brain Development

The Impact of Stress on Fetal Brain Development

Sponsor

University Hospital Tuebingen

Enrollment

24 participants

Start Date

Feb 1, 2019

Study Type

OBSERVATIONAL

Conditions

Pregnancy

Summary

The current proposal aims to investigate the impact of acute stress on the fetal autonomic nervous system.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Betamethason Sodium Phosphate for people with pregnancy. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBetamethason Sodium Phosphate

First measurement: 12-36 hours after betamethasone treatment Second measurement: within five days after betamethasone treatment and two weeks Third measurement (neonatal measurement): 1-8 weeks after birh

Locations(1)

University Hospital Tuebingen, Department of Women's Health

Tübingen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03831126

Related Trials

Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy

NCT061132372 locations

Determinant Factors in Excessive Gestational Weight Gain: Physical Activity, Nutritional Status, and Anxiety

NCT073684651 location